"South Carolina's Low Country residents now have access to high-tech medical services all under one roof with the opening of the St. Joseph's/Candler Bluffton Campus at Buckwalter Place. Phawe I included radiation oncology, medical oncology, infusion services, PET-CT, visiting physician specialists, dietary/nutritional services, social workers, patient navigators and financial navigators"

During the past decade, Saint Joseph's/Candler - Bluffton Campus conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph's/Candler - Bluffton Campus" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph's/Candler - Bluffton Campus" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph's/Candler - Bluffton Campus" are "Invasive Breast Carcinoma" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (4 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Saint Joseph's/Candler - Bluffton Campus" in a lesser frequency.

Most popular intervention types in "Saint Joseph's/Candler - Bluffton Campus" are "Other" (27 trials), "Drug" (24 trials), "Procedure" (17 trials), "Biological" (14 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Biospecimen Collection" (14 trials), "Questionnaire Administration" (13 trials), "Computed Tomography" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph's/Candler - Bluffton Campus" are 30 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph's/Candler - Bluffton Campus". undefined are not yet recruiting, 26 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Saint Joseph's/Candler - Bluffton Campus, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph's/Candler - Bluffton Campus, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".